Daiwa Securities Group
ACHN

Daiwa Securities Group’s Achillion Pharmaceuticals ACHN Stock Holding History

Daiwa Securities Group’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-890
Closed -$5K – 1249
2019
Q4 		$5K Hold
890
– – ﹤0.01% 1116
2019
Q3 		$3K Buy
890
+128
+17% +$493 ﹤0.01% 1117
2019
Q2 		$2K Hold
762
– – ﹤0.01% 1166
2019
Q1 		$2K Hold
762
– – ﹤0.01% 1152
2018
Q4 		$1K Hold
762
– – ﹤0.01% 1139
2018
Q3 		$3K Hold
762
– – ﹤0.01% 1118
2018
Q2 		$2K Hold
762
– – ﹤0.01% 1154
2018
Q1 		$3K Buy
+762
New +$2.49K ﹤0.01% 1112

Daiwa Securities Group's ACHN Position: Q1 2020 in Review

Daiwa Securities Group sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 890 shares — an estimated $5K sold.

Daiwa Securities Group first reported a position in ACHN in Q1 2018 and held it in 8 quarters. The position peaked at $5K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Daiwa Securities Group reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Daiwa Securities Group sold 890 Achillion Pharmaceuticals shares in Q1 2020, an estimated $5K.
  • Daiwa Securities Group first reported a position in Achillion Pharmaceuticals in Q1 2018 and held it in 8 quarters.
  • Daiwa Securities Group's Achillion Pharmaceuticals position peaked at $5K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Daiwa Securities Group's 13F filing for Q1 2020, filed 14 May 2020.